| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |